Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hypertrichosis-acromegaloid facial appearance syndrome (HAFF) is a very rare multiple congenital abnormality syndrome manifesting from birth with progressive hypertrichosis congenita terminalis (thick scalp hair extending onto the forehead with generalized increased body hair) associated with a typical acromegaloid facial appearance (thick eyebrows, prominent supraorbital ridges, broad nasal bridge, anteverted nares, long and large philtrum, and prominent mouth with full lips) appearing during childhood. HAFF seems to belong to a spectrum of phenotypes with the clinically overlapping acromegaloid facial appearance syndrome and hypertrichotic osteochondrodysplasia, CantC9 type.
Biomarker and diagnostic research for hypertrichosis-acromegaloid facial appearance syndrome has been reported in the published literature.
No clinical trials have been registered for hypertrichosis-acromegaloid facial appearance syndrome.
372 publications have been identified in PubMed for hypertrichosis-acromegaloid facial appearance syndrome. Kisho has analyzed 88 by research type. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (32%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 29 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
28 |
32% |
Laboratory research | 15 | 17% |
Other research | 6 | 7% |
Testing and diagnosis research | 3 | 3% |
Clinical study results | 3 | 3% |
Disease patterns and progression | 3 | 3% |
New treatment approaches | 1 | 1% |
Müller SK (2026). [PMID: 41677806](https://pubmed.ncbi.nlm.nih.gov/41677806/). *HNO*. [Review / Meta-Analysis]
Sharma L (2026). [PMID: 30335302](https://pubmed.ncbi.nlm.nih.gov/30335302/). *Unknown Journal*. [Case Report / Case Series]
Tsatsopoulou A (2026). [PMID: 40316016](https://pubmed.ncbi.nlm.nih.gov/40316016/). *Hellenic J Cardiol*. [Review / Meta-Analysis]
Wang D (2026). [PMID: 41916887](https://pubmed.ncbi.nlm.nih.gov/41916887/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Review / Meta-Analysis]
Mroczek M (2026). [PMID: 41575592](https://pubmed.ncbi.nlm.nih.gov/41575592/). *Journal of neurology*. [Diagnostic / Biomarker]
Rogers DJ (2025). [PMID: 40387217](https://pubmed.ncbi.nlm.nih.gov/40387217/). *Journal of intellectual disability research : JIDR*. [Epidemiology / Natural History]
Dada S (2025). [PMID: 40447311](https://pubmed.ncbi.nlm.nih.gov/40447311/). *Journal of medical genetics*. [Case Report / Case Series]
Ng R (2025). [PMID: 40616444](https://pubmed.ncbi.nlm.nih.gov/40616444/). *Am J Med Genet A*. [Basic Science / Preclinical]
Schubert T (2025). [PMID: 38950199](https://pubmed.ncbi.nlm.nih.gov/38950199/). *Developmental medicine and child neurology*. [Review / Meta-Analysis]
Ogawa T (2025). [PMID: 39693239](https://pubmed.ncbi.nlm.nih.gov/39693239/). *The Journal of clinical endocrinology and metabolism*. [Review / Meta-Analysis]